GB
Gossamer Bio, Inc.
SEC filingBiotechnology · San Diego, CA
Amount raised$25Msold at filing
Total offering$150M$125M still open
Investors in the raise38count reported to the SEC
FiledSep 4, 2026first sale Aug 20, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Russell CoxDirector
Caryn D. PetersonExecutive Officer
Sandra J. MilliganDirector
Christian D. WaageExecutive Officer
Faheem HasnainExecutive Officer, Director
John D. QuiselDirector
Thomas DanielDirector
Steven D. NathanDirector
Skye J. DrynanDirector
Bryan D. GiraudoExecutive Officer
Robert D. SmithExecutive Officer
Executive officers, directors and promoters as listed on the Form D.